DK1200447T3 - Oxazinocarbazoler til behandling af CNS-sygdomme - Google Patents

Oxazinocarbazoler til behandling af CNS-sygdomme

Info

Publication number
DK1200447T3
DK1200447T3 DK00948738T DK00948738T DK1200447T3 DK 1200447 T3 DK1200447 T3 DK 1200447T3 DK 00948738 T DK00948738 T DK 00948738T DK 00948738 T DK00948738 T DK 00948738T DK 1200447 T3 DK1200447 T3 DK 1200447T3
Authority
DK
Denmark
Prior art keywords
oxazinocarbazoles
treatment
cns diseases
cns
diseases
Prior art date
Application number
DK00948738T
Other languages
English (en)
Inventor
Ruth E Tenbrink
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK1200447T3 publication Critical patent/DK1200447T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK00948738T 1999-07-28 2000-07-20 Oxazinocarbazoler til behandling af CNS-sygdomme DK1200447T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14601399P 1999-07-28 1999-07-28
PCT/US2000/019532 WO2001009142A1 (en) 1999-07-28 2000-07-20 Oxazinocarbazoles for the treatment of cns diseases

Publications (1)

Publication Number Publication Date
DK1200447T3 true DK1200447T3 (da) 2004-02-02

Family

ID=22515535

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00948738T DK1200447T3 (da) 1999-07-28 2000-07-20 Oxazinocarbazoler til behandling af CNS-sygdomme

Country Status (20)

Country Link
US (2) US6448397B1 (da)
EP (1) EP1200447B1 (da)
JP (1) JP2003506328A (da)
KR (1) KR20020015079A (da)
CN (1) CN1165539C (da)
AR (1) AR024963A1 (da)
AT (1) ATE251167T1 (da)
AU (1) AU767282B2 (da)
BR (1) BR0012791A (da)
CA (1) CA2376927A1 (da)
CO (1) CO5031298A1 (da)
DE (1) DE60005685T2 (da)
DK (1) DK1200447T3 (da)
ES (1) ES2208371T3 (da)
MX (1) MXPA02000984A (da)
PE (1) PE20010548A1 (da)
PT (1) PT1200447E (da)
TW (1) TWI222450B (da)
WO (1) WO2001009142A1 (da)
ZA (1) ZA200110539B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100497122B1 (ko) * 2001-08-30 2005-06-29 주식회사 삼양제넥스 페놀옥시다제 시스템을 구성하는 단백질 및 그것의 유전자
SE0103539D0 (sv) * 2001-10-23 2001-10-23 Biovitrum Ab New Use
DE60232173D1 (de) * 2001-11-09 2009-06-10 Biovitrum Ab Publ Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
EP1495031A1 (en) * 2002-04-16 2005-01-12 Pharmacia & Upjohn Company LLC Labeled oxazinocarbazoles as diagnostic agents
US6932961B1 (en) 2002-04-16 2005-08-23 Pharmacia & Upjohn Company Oxazinocarbazoles for the treatment of CNS diseases
TWI284124B (en) * 2002-12-03 2007-07-21 Hoffmann La Roche Aminoalkoxyindoles
BRPI0709817A2 (pt) * 2006-04-12 2011-07-26 Wyeth Corp composto da fàrmula i; mÉtodo para o tratamento de um distérbio do sistema nervoso central relacionado ou afetado pelo receptor de 5-ht6 em um paciente que necessita deste; composiÇço farmacÊutica; e processo para a preparaÇço de um composto da fàrmula i

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059491T3 (es) * 1987-06-29 1994-11-16 Duphar Int Res Derivados de indol con anillos condensados.
GB8812636D0 (en) 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
EP0377238A1 (en) 1988-12-22 1990-07-11 Duphar International Research B.V New annelated indolo (3,2-c)-lactams
AU7949694A (en) 1993-10-20 1995-05-08 Tokyo Tanabe Company Limited Indole derivative
EP0985671B1 (en) 1996-05-31 2003-04-02 Mochida Pharmaceutical Co., Ltd. PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT

Also Published As

Publication number Publication date
DE60005685D1 (de) 2003-11-06
AU6219700A (en) 2001-02-19
MXPA02000984A (es) 2002-07-30
JP2003506328A (ja) 2003-02-18
CN1361781A (zh) 2002-07-31
BR0012791A (pt) 2002-06-18
ES2208371T3 (es) 2004-06-16
US6821970B2 (en) 2004-11-23
US20020169317A1 (en) 2002-11-14
CN1165539C (zh) 2004-09-08
DE60005685T2 (de) 2004-08-12
ATE251167T1 (de) 2003-10-15
WO2001009142A1 (en) 2001-02-08
PE20010548A1 (es) 2001-05-13
TWI222450B (en) 2004-10-21
EP1200447A1 (en) 2002-05-02
ZA200110539B (en) 2003-03-24
KR20020015079A (ko) 2002-02-27
CA2376927A1 (en) 2001-02-08
AR024963A1 (es) 2002-10-30
EP1200447B1 (en) 2003-10-01
PT1200447E (pt) 2004-02-27
US6448397B1 (en) 2002-09-10
AU767282B2 (en) 2003-11-06
CO5031298A1 (es) 2001-04-27

Similar Documents

Publication Publication Date Title
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1028954T3 (da) Substituerede imidazoler egnede til behandling af inflammatoriske sygdomme
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
IS7099A (is) Efnasambönd til að meðhöndla bólgutruflanir
NO20031443D0 (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
DK1176964T3 (da) Brug af ET743 til behandling af cancer
DK1150991T3 (da) Præparater til behandling af inflammatoriske reaktioner
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DK1344526T3 (da) Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser
DK1468996T3 (da) Indolderivater til behandling af CNS-sygdomme
DK1200114T3 (da) PPAR delta inhibitorer til behandling af kardiovaskulære sygdomme
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1121356T3 (da) 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser
DK1225890T3 (da) Rivastigmin til behandling af öjensygdomme
NO20030717D0 (no) Forbindelser for behandling av avhengighetsforstyrrelser
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen
DK1458703T3 (da) Isochromanforbindelser til behandling af CNS-lidelser